nodes	percent_of_prediction	percent_of_DWPC	metapath
Dicyclomine—Drug hypersensitivity—Varenicline—nicotine dependence	0.0711	0.0826	CcSEcCtD
Dicyclomine—Thrombosis—Varenicline—nicotine dependence	0.0405	0.047	CcSEcCtD
Dicyclomine—Delusion—Varenicline—nicotine dependence	0.0405	0.047	CcSEcCtD
Dicyclomine—Mania—Varenicline—nicotine dependence	0.0394	0.0458	CcSEcCtD
Dicyclomine—Mydriasis—Varenicline—nicotine dependence	0.0359	0.0417	CcSEcCtD
Dicyclomine—Disorientation—Varenicline—nicotine dependence	0.0232	0.027	CcSEcCtD
Dicyclomine—Amnesia—Varenicline—nicotine dependence	0.0221	0.0257	CcSEcCtD
Dicyclomine—Lethargy—Varenicline—nicotine dependence	0.0212	0.0247	CcSEcCtD
Dicyclomine—Affect lability—Varenicline—nicotine dependence	0.0205	0.0238	CcSEcCtD
Dicyclomine—Urinary retention—Varenicline—nicotine dependence	0.0198	0.023	CcSEcCtD
Dicyclomine—Mood swings—Varenicline—nicotine dependence	0.0197	0.0229	CcSEcCtD
Dicyclomine—Breast disorder—Varenicline—nicotine dependence	0.0188	0.0218	CcSEcCtD
Dicyclomine—Abdominal distension—Varenicline—nicotine dependence	0.0181	0.021	CcSEcCtD
Dicyclomine—Erectile dysfunction—Varenicline—nicotine dependence	0.0166	0.0192	CcSEcCtD
Dicyclomine—Hallucination—Varenicline—nicotine dependence	0.0143	0.0166	CcSEcCtD
Dicyclomine—Hypoaesthesia—Varenicline—nicotine dependence	0.0143	0.0166	CcSEcCtD
Dicyclomine—Eye disorder—Varenicline—nicotine dependence	0.0134	0.0156	CcSEcCtD
Dicyclomine—Cardiac disorder—Varenicline—nicotine dependence	0.0134	0.0155	CcSEcCtD
Dicyclomine—Immune system disorder—Varenicline—nicotine dependence	0.013	0.0151	CcSEcCtD
Dicyclomine—Mediastinal disorder—Varenicline—nicotine dependence	0.013	0.0151	CcSEcCtD
Dicyclomine—Mental disorder—Varenicline—nicotine dependence	0.0126	0.0146	CcSEcCtD
Dicyclomine—Erythema—Varenicline—nicotine dependence	0.0125	0.0145	CcSEcCtD
Dicyclomine—Vision blurred—Varenicline—nicotine dependence	0.0118	0.0137	CcSEcCtD
Dicyclomine—Ill-defined disorder—Varenicline—nicotine dependence	0.0116	0.0135	CcSEcCtD
Dicyclomine—CYP1A1—Xenobiotics—CYP2A7—nicotine dependence	0.0115	0.0829	CbGpPWpGaD
Dicyclomine—Agitation—Varenicline—nicotine dependence	0.0115	0.0134	CcSEcCtD
Dicyclomine—Angioedema—Varenicline—nicotine dependence	0.0114	0.0133	CcSEcCtD
Dicyclomine—Malaise—Varenicline—nicotine dependence	0.0113	0.0131	CcSEcCtD
Dicyclomine—Syncope—Varenicline—nicotine dependence	0.0112	0.013	CcSEcCtD
Dicyclomine—Palpitations—Varenicline—nicotine dependence	0.0111	0.0129	CcSEcCtD
Dicyclomine—Loss of consciousness—Varenicline—nicotine dependence	0.011	0.0128	CcSEcCtD
Dicyclomine—Hypertension—Varenicline—nicotine dependence	0.0108	0.0126	CcSEcCtD
Dicyclomine—Discomfort—Varenicline—nicotine dependence	0.0105	0.0122	CcSEcCtD
Dicyclomine—Dry mouth—Varenicline—nicotine dependence	0.0104	0.0121	CcSEcCtD
Dicyclomine—Oedema—Varenicline—nicotine dependence	0.0102	0.0119	CcSEcCtD
Dicyclomine—Shock—Varenicline—nicotine dependence	0.0101	0.0117	CcSEcCtD
Dicyclomine—Nervous system disorder—Varenicline—nicotine dependence	0.01	0.0116	CcSEcCtD
Dicyclomine—Tachycardia—Varenicline—nicotine dependence	0.00998	0.0116	CcSEcCtD
Dicyclomine—Anorexia—Varenicline—nicotine dependence	0.00974	0.0113	CcSEcCtD
Dicyclomine—Insomnia—Varenicline—nicotine dependence	0.00925	0.0107	CcSEcCtD
Dicyclomine—Dyspnoea—Varenicline—nicotine dependence	0.00911	0.0106	CcSEcCtD
Dicyclomine—Somnolence—Varenicline—nicotine dependence	0.00909	0.0106	CcSEcCtD
Dicyclomine—Dyspepsia—Varenicline—nicotine dependence	0.009	0.0105	CcSEcCtD
Dicyclomine—Decreased appetite—Varenicline—nicotine dependence	0.00889	0.0103	CcSEcCtD
Dicyclomine—Gastrointestinal disorder—Varenicline—nicotine dependence	0.00882	0.0103	CcSEcCtD
Dicyclomine—Fatigue—Varenicline—nicotine dependence	0.00881	0.0102	CcSEcCtD
Dicyclomine—Pain—Varenicline—nicotine dependence	0.00874	0.0102	CcSEcCtD
Dicyclomine—Constipation—Varenicline—nicotine dependence	0.00874	0.0102	CcSEcCtD
Dicyclomine—Feeling abnormal—Varenicline—nicotine dependence	0.00842	0.00979	CcSEcCtD
Dicyclomine—Gastrointestinal pain—Varenicline—nicotine dependence	0.00836	0.00971	CcSEcCtD
Dicyclomine—Urticaria—Varenicline—nicotine dependence	0.00812	0.00943	CcSEcCtD
Dicyclomine—Abdominal pain—Varenicline—nicotine dependence	0.00808	0.00939	CcSEcCtD
Dicyclomine—Hypersensitivity—Varenicline—nicotine dependence	0.00753	0.00875	CcSEcCtD
Dicyclomine—Asthenia—Varenicline—nicotine dependence	0.00733	0.00852	CcSEcCtD
Dicyclomine—Pruritus—Varenicline—nicotine dependence	0.00723	0.0084	CcSEcCtD
Dicyclomine—Dizziness—Varenicline—nicotine dependence	0.00676	0.00785	CcSEcCtD
Dicyclomine—Vomiting—Varenicline—nicotine dependence	0.0065	0.00755	CcSEcCtD
Dicyclomine—Rash—Varenicline—nicotine dependence	0.00645	0.00749	CcSEcCtD
Dicyclomine—Dermatitis—Varenicline—nicotine dependence	0.00644	0.00748	CcSEcCtD
Dicyclomine—Headache—Varenicline—nicotine dependence	0.0064	0.00744	CcSEcCtD
Dicyclomine—Nausea—Varenicline—nicotine dependence	0.00607	0.00705	CcSEcCtD
Dicyclomine—CYP1A1—Cytochrome P450 - arranged by substrate type—CYP2A7—nicotine dependence	0.00479	0.0344	CbGpPWpGaD
Dicyclomine—CYP1A1—Oxidation by Cytochrome P450—CYP2A7—nicotine dependence	0.00473	0.034	CbGpPWpGaD
Dicyclomine—CHRM1—Monoamine GPCRs—DRD2—nicotine dependence	0.00462	0.0332	CbGpPWpGaD
Dicyclomine—CHRM3—Monoamine GPCRs—DRD2—nicotine dependence	0.0046	0.0331	CbGpPWpGaD
Dicyclomine—CHRM2—Monoamine GPCRs—DRD2—nicotine dependence	0.00456	0.0328	CbGpPWpGaD
Dicyclomine—CYP1A1—Phase 1 - Functionalization of compounds—CYP2A7—nicotine dependence	0.00389	0.0279	CbGpPWpGaD
Dicyclomine—CHRM1—Amine ligand-binding receptors—DRD2—nicotine dependence	0.00388	0.0279	CbGpPWpGaD
Dicyclomine—CHRM3—Amine ligand-binding receptors—DRD2—nicotine dependence	0.00387	0.0278	CbGpPWpGaD
Dicyclomine—CHRM2—Amine ligand-binding receptors—DRD2—nicotine dependence	0.00383	0.0275	CbGpPWpGaD
Dicyclomine—CHRM1—Regulation of Actin Cytoskeleton—FGD1—nicotine dependence	0.00356	0.0256	CbGpPWpGaD
Dicyclomine—CHRM3—Regulation of Actin Cytoskeleton—FGD1—nicotine dependence	0.00355	0.0255	CbGpPWpGaD
Dicyclomine—CHRM2—Regulation of Actin Cytoskeleton—FGD1—nicotine dependence	0.00351	0.0253	CbGpPWpGaD
Dicyclomine—CHRM2—G alpha (i) signalling events—TAS2R16—nicotine dependence	0.00311	0.0224	CbGpPWpGaD
Dicyclomine—CHRM2—SIDS Susceptibility Pathways—CHRNB4—nicotine dependence	0.00267	0.0192	CbGpPWpGaD
Dicyclomine—CHRM1—Regulation of Actin Cytoskeleton—WASF2—nicotine dependence	0.00222	0.0159	CbGpPWpGaD
Dicyclomine—CHRM3—Regulation of Actin Cytoskeleton—WASF2—nicotine dependence	0.00221	0.0159	CbGpPWpGaD
Dicyclomine—CYP1A1—Metapathway biotransformation—AKR1B10—nicotine dependence	0.00219	0.0157	CbGpPWpGaD
Dicyclomine—CHRM2—Regulation of Actin Cytoskeleton—WASF2—nicotine dependence	0.00219	0.0157	CbGpPWpGaD
Dicyclomine—CHRM1—Regulation of Actin Cytoskeleton—WASF1—nicotine dependence	0.00212	0.0153	CbGpPWpGaD
Dicyclomine—CHRM3—Regulation of Actin Cytoskeleton—WASF1—nicotine dependence	0.00212	0.0152	CbGpPWpGaD
Dicyclomine—CHRM2—Regulation of Actin Cytoskeleton—WASF1—nicotine dependence	0.0021	0.0151	CbGpPWpGaD
Dicyclomine—CYP1A1—Biological oxidations—CYP2A7—nicotine dependence	0.00206	0.0148	CbGpPWpGaD
Dicyclomine—CYP1A1—Metapathway biotransformation—CYP2A7—nicotine dependence	0.00204	0.0146	CbGpPWpGaD
Dicyclomine—CHRM1—GPCR ligand binding—TAS2R16—nicotine dependence	0.00191	0.0137	CbGpPWpGaD
Dicyclomine—CHRM3—GPCR ligand binding—TAS2R16—nicotine dependence	0.0019	0.0137	CbGpPWpGaD
Dicyclomine—CHRM2—GPCR ligand binding—TAS2R16—nicotine dependence	0.00188	0.0135	CbGpPWpGaD
Dicyclomine—CHRM2—SIDS Susceptibility Pathways—CHRNB2—nicotine dependence	0.00178	0.0128	CbGpPWpGaD
Dicyclomine—CHRM2—SIDS Susceptibility Pathways—CHRNA4—nicotine dependence	0.00162	0.0116	CbGpPWpGaD
Dicyclomine—CHRM1—Circadian rythm related genes—CHRNB2—nicotine dependence	0.00147	0.0106	CbGpPWpGaD
Dicyclomine—CHRM2—G alpha (i) signalling events—OPRM1—nicotine dependence	0.00131	0.00942	CbGpPWpGaD
Dicyclomine—CHRM1—GPCRs, Class A Rhodopsin-like—OPRM1—nicotine dependence	0.00123	0.00886	CbGpPWpGaD
Dicyclomine—CHRM3—GPCRs, Class A Rhodopsin-like—OPRM1—nicotine dependence	0.00123	0.00883	CbGpPWpGaD
Dicyclomine—CHRM2—GPCRs, Class A Rhodopsin-like—OPRM1—nicotine dependence	0.00122	0.00874	CbGpPWpGaD
Dicyclomine—CHRM1—Circadian rythm related genes—DRD2—nicotine dependence	0.00109	0.00782	CbGpPWpGaD
Dicyclomine—CHRM1—GPCR downstream signaling—TAS2R16—nicotine dependence	0.00108	0.00775	CbGpPWpGaD
Dicyclomine—CHRM3—GPCR downstream signaling—TAS2R16—nicotine dependence	0.00107	0.00772	CbGpPWpGaD
Dicyclomine—CHRM2—GPCR downstream signaling—TAS2R16—nicotine dependence	0.00106	0.00765	CbGpPWpGaD
Dicyclomine—CHRM1—Class A/1 (Rhodopsin-like receptors)—OPRM1—nicotine dependence	0.00106	0.00759	CbGpPWpGaD
Dicyclomine—CHRM3—Class A/1 (Rhodopsin-like receptors)—OPRM1—nicotine dependence	0.00105	0.00756	CbGpPWpGaD
Dicyclomine—CHRM2—Class A/1 (Rhodopsin-like receptors)—OPRM1—nicotine dependence	0.00104	0.00749	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling by GPCR—TAS2R16—nicotine dependence	0.000979	0.00704	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling by GPCR—TAS2R16—nicotine dependence	0.000976	0.00701	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling by GPCR—TAS2R16—nicotine dependence	0.000966	0.00694	CbGpPWpGaD
Dicyclomine—CHRM2—G alpha (i) signalling events—DRD2—nicotine dependence	0.000948	0.00681	CbGpPWpGaD
Dicyclomine—CHRM1—GPCRs, Class A Rhodopsin-like—DRD2—nicotine dependence	0.000891	0.0064	CbGpPWpGaD
Dicyclomine—CHRM3—GPCRs, Class A Rhodopsin-like—DRD2—nicotine dependence	0.000888	0.00638	CbGpPWpGaD
Dicyclomine—CHRM2—GPCRs, Class A Rhodopsin-like—DRD2—nicotine dependence	0.00088	0.00632	CbGpPWpGaD
Dicyclomine—CHRM1—GPCR downstream signaling—FGD1—nicotine dependence	0.000846	0.00608	CbGpPWpGaD
Dicyclomine—CHRM3—GPCR downstream signaling—FGD1—nicotine dependence	0.000843	0.00606	CbGpPWpGaD
Dicyclomine—CHRM2—GPCR downstream signaling—FGD1—nicotine dependence	0.000835	0.006	CbGpPWpGaD
Dicyclomine—CHRM1—GPCR ligand binding—OPRM1—nicotine dependence	0.000804	0.00578	CbGpPWpGaD
Dicyclomine—CHRM3—GPCR ligand binding—OPRM1—nicotine dependence	0.000802	0.00576	CbGpPWpGaD
Dicyclomine—CHRM2—GPCR ligand binding—OPRM1—nicotine dependence	0.000794	0.0057	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling by GPCR—FGD1—nicotine dependence	0.000768	0.00552	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling by GPCR—FGD1—nicotine dependence	0.000766	0.0055	CbGpPWpGaD
Dicyclomine—CHRM1—Class A/1 (Rhodopsin-like receptors)—DRD2—nicotine dependence	0.000764	0.00549	CbGpPWpGaD
Dicyclomine—CHRM3—Class A/1 (Rhodopsin-like receptors)—DRD2—nicotine dependence	0.000761	0.00547	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling by GPCR—FGD1—nicotine dependence	0.000758	0.00545	CbGpPWpGaD
Dicyclomine—CHRM2—Class A/1 (Rhodopsin-like receptors)—DRD2—nicotine dependence	0.000754	0.00542	CbGpPWpGaD
Dicyclomine—CHRM1—GPCR ligand binding—DRD2—nicotine dependence	0.000581	0.00418	CbGpPWpGaD
Dicyclomine—CHRM3—GPCR ligand binding—DRD2—nicotine dependence	0.00058	0.00416	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—TAS2R16—nicotine dependence	0.000578	0.00416	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—TAS2R16—nicotine dependence	0.000577	0.00414	CbGpPWpGaD
Dicyclomine—CHRM2—GPCR ligand binding—DRD2—nicotine dependence	0.000574	0.00412	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—TAS2R16—nicotine dependence	0.000571	0.0041	CbGpPWpGaD
Dicyclomine—CHRM1—GPCR downstream signaling—OPRM1—nicotine dependence	0.000454	0.00327	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—FGD1—nicotine dependence	0.000454	0.00326	CbGpPWpGaD
Dicyclomine—CHRM3—GPCR downstream signaling—OPRM1—nicotine dependence	0.000453	0.00326	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—FGD1—nicotine dependence	0.000452	0.00325	CbGpPWpGaD
Dicyclomine—CHRM2—GPCR downstream signaling—OPRM1—nicotine dependence	0.000449	0.00322	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—FGD1—nicotine dependence	0.000448	0.00322	CbGpPWpGaD
Dicyclomine—CHRM3—Metabolism—CYP2A7—nicotine dependence	0.000444	0.00319	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling by GPCR—OPRM1—nicotine dependence	0.000413	0.00297	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling by GPCR—OPRM1—nicotine dependence	0.000411	0.00296	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling by GPCR—OPRM1—nicotine dependence	0.000407	0.00293	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—AKR1B10—nicotine dependence	0.000401	0.00288	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—AKR1B10—nicotine dependence	0.0004	0.00287	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—AKR1B10—nicotine dependence	0.000396	0.00284	CbGpPWpGaD
Dicyclomine—CYP1A1—Metabolism—CYP2A7—nicotine dependence	0.000353	0.00254	CbGpPWpGaD
Dicyclomine—CHRM1—GPCR downstream signaling—DRD2—nicotine dependence	0.000329	0.00236	CbGpPWpGaD
Dicyclomine—CHRM3—GPCR downstream signaling—DRD2—nicotine dependence	0.000328	0.00235	CbGpPWpGaD
Dicyclomine—CHRM2—GPCR downstream signaling—DRD2—nicotine dependence	0.000324	0.00233	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling by GPCR—DRD2—nicotine dependence	0.000298	0.00214	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling by GPCR—DRD2—nicotine dependence	0.000297	0.00214	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling by GPCR—DRD2—nicotine dependence	0.000295	0.00212	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—WASF2—nicotine dependence	0.000282	0.00203	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—WASF2—nicotine dependence	0.000282	0.00202	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—WASF2—nicotine dependence	0.000279	0.002	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—WASF1—nicotine dependence	0.000271	0.00195	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—WASF1—nicotine dependence	0.00027	0.00194	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—WASF1—nicotine dependence	0.000267	0.00192	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—OPRM1—nicotine dependence	0.000244	0.00175	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—OPRM1—nicotine dependence	0.000243	0.00175	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—OPRM1—nicotine dependence	0.000241	0.00173	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—DRD2—nicotine dependence	0.000176	0.00127	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—DRD2—nicotine dependence	0.000176	0.00126	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—DRD2—nicotine dependence	0.000174	0.00125	CbGpPWpGaD
